Cursano Giulia
Assegnista di tipo B
Competenze e ambito di ricerca
Contacts
E-mail di ateneo
Research
Publications
-
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial / G. Marvaso, G. Corrao, M. Zaffaroni, M.G. Vincini, C. Lorubbio, S. Gandini, C. Fodor, S. Netti, D. Zerini, S. Luzzago, F.A. Mistretta, K. Venetis, G. Cursano, T. Burla, K. Mazzocco, F. Cattani, G. Petralia, N. Fusco, G. Pravettoni, G. Musi, O. De Cobelli, C. Tang, P. Ost, D.A. Palma, R. Orecchia, B.A. Jereczek-Fossa. - In: THE LANCET ONCOLOGY. - ISSN 1470-2045. - 26:3(2025 Mar), pp. 300-311. [10.1016/S1470-2045(24)00730-7]
-
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact / K. Venetis, C. Frascarelli, L.B. Bielo, G. Cursano, R. Adorisio, M. Ivanova, E. Mane, V. Peruzzo, A. Concardi, M. Negrelli, M. D'Ercole, F.M. Porta, Y. Zhan, A. Marra, D. Trapani, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 217:(2025 Feb 25), pp. 115233.1-115233.10. [10.1016/j.ejca.2025.115233]
-
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer / E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 201:(2024 Sep), pp. 104427.1-104427.6. [10.1016/j.critrevonc.2024.104427]
-
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy / K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 25:11(2024), pp. 5717.1-5717.13. [10.3390/ijms25115717]
-
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer / M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco. - In: VIRCHOWS ARCHIV. - ISSN 0945-6317. - 484:1(2024), pp. 3-14. [10.1007/s00428-023-03656-w]